Evidence map›Paper›PMID 39931216›Full record

ArticleDrug design, development and therapy2025

Asiaticoside Attenuates Chronic Restraint Stress-Induced Hippocampal CA1 Neuronal Ferroptosis via Activating BDNF/Nrf2/GPX4 Signaling Pathway.

An Zhou, Hao-Yinghua Feng, Chu-Ning Fan, Jun Wang, Zhong-Yu Yuan, Guang-Hui Xu, Cheng-Fu Li, Wei-Feng Huang, Li-Tao Yi

Abstract read
In one paragraph

Article in Drug design, development and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Therapeutic potential ofPharmaceutical biology · 2026
    Review
  3. Review
  4. Article
  5. Ferroptosis in depression: mechanisms, association, and therapeutic strategies.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  6. Food science and biotechnology · 2026
    Article
  7. Review
  8. Article
  9. Life (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

An ZhouDepartment of Gastroenterology and Hepatology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian Province, 361003, People's Republic of China.
Hao-Yinghua FengCollege of Pharmacy, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong province, 510006, People's Republic of China.
Chu-Ning FanDepartment of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, 361021, People's Republic of China.
Jun WangDepartment of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, 361021, People's Republic of China.
Zhong-Yu YuanDepartment of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, 361021, People's Republic of China.
Guang-Hui XuXiamen Medicine Research Institute, Xiamen, Fujian Province, 361008, People's Republic of China.
Cheng-Fu LiXiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian Province, 361009, People's Republic of China.
Wei-Feng HuangDepartment of Gastroenterology and Hepatology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian Province, 361003, People's Republic of China.ORCID 0000-0002-9755-7299
Li-Tao YiDepartment of Chemical and Pharmaceutical Engineering, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian Province, 361021, People's Republic of China.ORCID 0000-0001-9052-8607

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Ferroptosis, characterized by iron-dependent lipid reactive oxygen species accumulation, plays a critical role in the pathophysiology of depression. Our research aims to elucidate the potential antidepressant mechanisms of asiaticoside, a bioactive compound known for its neuroprotective and immunomodulatory properties. Methods: The antidepressant-like properties of asiaticoside in a model of chronic restraint stress (CRS)-induced depression in mice, with a particular focus on its interaction with ferroptosis-related pathways. Results: The behavioral results revealed that asiaticoside significantly ameliorated CRS-induced depressive symptoms, as evidenced by increased sucrose preference and reduced immobility time. At the molecular level, asiaticoside enhanced the expression of brain-derived neurotrophic factor (BDNF), phosphorylated tropomyosin receptor kinase B (pTrkB), phosphorylated nuclear factor erythroid 2-related factor 2 (pNrf2), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11), indicating its neuroprotective and antioxidative effects. In addition, asiaticoside suppressed the expression of ferroptosis markers, including ferritin light chain (FLC) and transferrin receptor only in CA1 region. Transmission electron microscopy (TEM) further confirmed that asiaticoside preserved mitochondrial integrity in CA1 neuronal cells. Conclusion: In conclusion, our findings suggest that asiaticoside exerts its antidepressant-like effects through the modulation of BDNF/Nrf2/GPX4 signaling pathway against neuronal ferroptosis in the hippocampal CA1 region.

Indexed as

Antidepressive AgentsBrain-Derived Neurotrophic FactorCA1 Region, HippocampalDepressionFerroptosisNeuronsNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseStress, PsychologicalTriterpenesAnimalsDisease Models, AnimalDose-Response Relationship, DrugMaleMiceMice, Inbred C57BLAntidepressive AgentsasiaticosideBdnf protein, mouseBrain-Derived Neurotrophic FactorNeuroprotective AgentsNfe2l2 protein, mouseNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseTriterpenesantidepressantasiaticosideBDNFferroptosisGPX4Nrf2

Identifiers

PMID39931216
PMCPMC11808218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.